Descripción
About the Role: Lead Global Pricing Strategiesandpricing decisions acrosstheportfolio to enable patient access while maximizing the value of Takeda products. Infuses pricing excellence and a value-based mindset throughout all strategic pricing activities. How you will contribute: - Be a key partner, represent the Global Pricing team and serve as the primary point-of-contact for assigned markets within the IBU structure, holding responsibility for providing pricing-implementation support aligned with pricing guidance and governance. - Provide/withhold endorsement of product price proposals consistent with global guidance & governance at launch and any list & net price post-launch for assigned markets (considering IRP and adherence to global pricing strategies). - Monitor implementation of local pricing governance, including the harmonization of pricing definitions and adherence to global pricing governance. - Collaborate closely with Global Access Strategy to develop access and pricing strategies for allocated late-stage pipeline and launch assets, and with IBU Access teams to ensure seamless execution across launch and inline products. - Develop and update pricing guidance and price strategy aligned with access strategy (e.g. tiered pricing, MRP, LRF) assets including Lifecycle Management, and LOE strategy to maximize the asset/portfolio value in close partnership with Global Access Strategy (for new launches) and for IBU Access team for inline products. - Drive and coordinate pricing research activities for late-stage pipeline, close Launch and inline products, in close collaboration with global and cross-functional teams (e.g., Market Access Strategy, IBU Access Team), to contribute to asset access strategy and price guidance development. - Identify and monitor competitive pricing policy trends for allocated geographies, synthesize competitor pricing information (including biosimilars and generics) for allocated assets, and initiate appropriate actions in close co